MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Land |
 Schweiz |
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
91.6 M |
Marktkapitalisierung |
$ 1.1 M |
EBITDA (LTM) |
$ -209 M |
P/E (LTM) |
- |
P/S (LTM) |
0.02 |
EPS (LTM) |
-71.8 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Bioventus
BVS
|
$ 9.26 | 1.09 % | $ 617 M | Nasdaq Global Select Market |  USA |
 |
Neuronetics
STIM
|
$ 1.33 | -5.0 % | $ 87.7 M | Nasdaq Global Select Market | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
|
Biodesix
BDSX
|
$ 14.6 | -3.63 % | $ 1.89 B | Nasdaq Global Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Medpace Holdings
MEDP
|
$ 466.6 | -0.04 % | $ 13.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 488.85 | -0.39 % | $ 184 B | NYSE,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Myriad Genetics
MYGN
|
$ 4.62 | -1.28 % | $ 428 M | Nasdaq Global Select Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 46.75 | -3.89 % | $ 2.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
RadNet
RDNT
|
$ 59.41 | -2.06 % | $ 4.47 B | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 165.13 | -0.46 % | $ 8.18 B | NYSE,SPB | USA |
 |
VolitionRx Limited
VNRX
|
$ 0.19 | 0.89 % | $ 18.3 M | NYSE American |  Singapore |
 |
Soleno Therapeutics
SLNO
|
$ 31.83 | -0.03 % | $ 1.62 B | Nasdaq Capital Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.59 | 22.4 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.73 | 2.37 % | $ 7.59 M | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Trinity Biotech plc
TRIB
|
$ 0.61 | 1.07 % | $ 61.9 M | Nasdaq Global Select Market |  Irlanda |
 |
Celcuity
CELC
|
$ 114.81 | 4.16 % | $ 4.53 B | Nasdaq Global Select Market | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 268.38 | 0.89 % | $ 22.3 B | NYSE,SPB | USA |
 |
NeoGenomics
NEO
|
$ 7.76 | -0.13 % | $ 994 M | Nasdaq Global Select Market,SPB | USA |
 |
Waters Corporation
WAT
|
$ 300.56 | -0.58 % | $ 17.9 B | NYSE,SPB | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Precipio
PRPO
|
$ 27.2 | -0.15 % | $ 35.3 M | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 17.47 | -3.37 % | $ 931 M | Nasdaq Global Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.11 | -2.31 % | $ 4.85 M | Nasdaq Capital Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 8.45 | 9.74 % | $ 33.7 M | Nasdaq Capital Market | Israel |
 |
DexCom
DXCM
|
$ 66.09 | -1.12 % | $ 25.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | Britain |